BOBCAT

Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation

Development of pharmaceutical products for others; pharmaceutical product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; pharmaceutical products development; pharmaceutical research services; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of medical products